Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
Objectif de Cours de WallStreet
66 195.67 INRRatio C/B
59.8829Rendement du dividende
1.86 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés THYROCARE
Analyse des dividendes THYROCARE
Croissance des dividendes sur 5 ans
80 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
96 %Historique des dividendes THYROCARE
Valorisation des titres THYROCARE
financières THYROCARE
Résultats | 2019 | Dynamique |